These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
505 related items for PubMed ID: 17288638
1. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study. Degenhardt L, Tennant C, Gilmour S, Schofield D, Nash L, Hall W, McKay D. Psychol Med; 2007 Jul; 37(7):927-34. PubMed ID: 17288638 [Abstract] [Full Text] [Related]
2. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls. Korver N, Nieman DH, Becker HE, van de Fliert JR, Dingemans PH, de Haan L, Spiering M, Schmitz N, Linszen DH. Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725 [Abstract] [Full Text] [Related]
3. Predictors of cannabis use in men with and without psychosis. Green B, Kavanagh DJ, Young RM. Addict Behav; 2007 Dec; 32(12):2879-87. PubMed ID: 17544588 [Abstract] [Full Text] [Related]
4. Cannabis use predicts future psychotic symptoms, and vice versa. Ferdinand RF, Sondeijker F, van der Ende J, Selten JP, Huizink A, Verhulst FC. Addiction; 2005 May; 100(5):612-8. PubMed ID: 15847618 [Abstract] [Full Text] [Related]
5. Cannabis abuse and severity of psychotic and affective disorders in Israeli psychiatric inpatients. Katz G, Durst R, Shufman E, Bar-Hamburger R, Grunhaus L. Compr Psychiatry; 2010 May; 51(1):37-41. PubMed ID: 19932824 [Abstract] [Full Text] [Related]
6. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis. Mata I, Rodríguez-Sánchez JM, Pelayo-Terán JM, Pérez-Iglesias R, González-Blanch C, Ramírez-Bonilla M, Martínez-García O, Vázquez-Barquero JL, Crespo-Facorro B. Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495 [Abstract] [Full Text] [Related]
7. Clinical characteristics influencing age at onset in psychotic disorders. Ongür D, Lin L, Cohen BM. Compr Psychiatry; 2009 Sep; 50(1):13-9. PubMed ID: 19059508 [Abstract] [Full Text] [Related]
11. Subjective effects of cannabis before the first psychotic episode. Peters BD, de Koning P, Dingemans P, Becker H, Linszen DH, de Haan L. Aust N Z J Psychiatry; 2009 Dec; 43(12):1155-62. PubMed ID: 20001415 [Abstract] [Full Text] [Related]
18. Early exposure to cannabis and risk for psychosis in young adolescents in Trinidad. Konings M, Henquet C, Maharajh HD, Hutchinson G, Van Os J. Acta Psychiatr Scand; 2008 Sep; 118(3):209-13. PubMed ID: 18452569 [Abstract] [Full Text] [Related]
19. COMT ValMet moderation of cannabis-induced psychosis: a momentary assessment study of 'switching on' hallucinations in the flow of daily life. Henquet C, Rosa A, Delespaul P, Papiol S, Fananás L, van Os J, Myin-Germeys I. Acta Psychiatr Scand; 2009 Feb; 119(2):156-60. PubMed ID: 18808401 [Abstract] [Full Text] [Related]
20. Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis. González-Ortega I, Alberich S, Echeburúa E, Aizpuru F, Millán E, Vieta E, Matute C, González-Pinto A. PLoS One; 2015 Feb; 10(4):e0123707. PubMed ID: 25875862 [Abstract] [Full Text] [Related] Page: [Next] [New Search]